Patients With Severe Asthma Benefit From Antibody Injection, Researchers Find

Mepolizumab works by blocking the production of eosinophils. By preventing their production, researchers were able to improve asthma, reduce the need for prednisone and really show that eosinophils are important in causing asthma symptoms in these patients.

Read the whole article on Science Daily

More from Science Daily